| Application no. and date | 14735770.1 (espacenet) (Federated) (European Patent Register), 20140605 | | Patent/reg. no. and date | DK/EP 3003284, 20200212 | | Publication date | 20160413 | | Priority no. and date | US 201361831909 P, 20130606 | | EP pub. no. and date |
EP 3003284 20160413 | | Effective date | | | Applicant/owner | Fibrogen, Inc., 409 Illinois Street
San Francisco, CA 94158, US | | Applicant ref. no. | P72341DK01 | | Inventor | CONCA, David, c/o Fibrogen Inc.
409 Illinois Street
San Francisco, CA 94158, US,
FLIPPIN, Lee, Allen, c/o Fibrogen Inc.
409 Illinois Street
San Francisco, CA 94158, US,
LEIGH, Scott, David, c/o Fibrogen Inc.
409 Illinois Street
San Francisco, CA 94158, US,
WITSCHI, Claudia, c/o Fibrogen Inc.
409 Illinois Street
San Francisco, CA 94158, US,
WRIGHT, Lee, Robert, c/o Fibrogen Inc.
409 Illinois Street
San Francisco, CA 94158, US | | Representative | Plougmann Vingtoft A/S, Strandvejen 70, 2900 Hellerup, DK | | Opponent | | | IPC Class | A61K 31/472 (2006.01) , A61K 9/28 (2006.01) , A61K 9/48 (2006.01) , A61K 9/20 (2006.01) | | Title | FARMACEUTISKE FORMULERINGER AF EN HIF-HYDROXYLASE-INHIBITOR | | Int. application no. | US2014041021 | | Int. publication no. | WO2014197660 | | Related patent (certificate) | | | Status | DK/EP patent | | Pædiatrisk forlængelse | - | | Udløbsdato for pædiatrisk forlængelse | - |
|
